Giant cell tumor of the eleventh thoracic vertebra in a pediatric patient: an interesting case report and comprehensive literature review

  • Kadir Oktay
  • Ebru Guzel
  • Serkan Simsek
  • Aslan Guzel
Case Report



Giant cell tumors of the mobile spinal column are very rare tumors, especially in the pediatric age group. Although they are benign tumors, they have locally aggressive growth pattern and high risk of recurrence.

Case presentation

We report a 15-year-old female patient with thoracic giant cell tumor who underwent percutaneous vertebroplasty and had cement extravasation into the spinal canal. Because of the deterioration of the patient’s neurological condition, total enbloc spondylectomy and cement excision were performed. She underwent instrumentation and fusion procedures in order to prevent spinal instability.


The main purpose of the treatment is gross total resection of the giant cell tumor. However, adjuvant methods such as denosumab should be added to the treatment protocol in patients who are older than 2 years old and can not undergo gross total resection due to tumor size and anatomic localization.


Giant cell tumor Pediatric Mobile spinal column Spondylectomy Vertebroplasty Cement extravasation 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G (2008) Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol 134(9):969–978CrossRefGoogle Scholar
  2. 2.
    Ben Nsir A, Ben Said I, Badri M, Boughamoura M, Jemel H (2015) Giant cell tumor of the sixth thoracic vertebra: case report. Turk Neurosurg 25(3):475–478PubMedGoogle Scholar
  3. 3.
    de Carvalho Cavalcante RA, Silva Marques RA, dos Santos VG, Sabino E, Fraga AC Jr, Zaccariotti VA, Arruda JB, Fernandes YB (2016) Lumbar spondylectomy for giant cell tumor after denosumab therapy. Spine (Phila Pa 1976) 41(3):E178–E182CrossRefGoogle Scholar
  4. 4.
    Kajiwara D, Kamoda H, Yonemoto T, Iwata S, Ishii T, Tsukanishi T, Ohtori S, Yamazaki M, Okawa A (2016) Denosumab for treatment of a recurrent cervical giant-cell tumor. Asian Spine J 10(3):553–557CrossRefGoogle Scholar
  5. 5.
    Sigwalt L, Bourgeois E, Eid A, Durand C, Griffet J, Courvoisier A (2016) A thoracic spinal bone giant cell tumor in a skeletally immature girl. A case report and literature review. Childs Nerv Syst 32(5):873–876CrossRefGoogle Scholar
  6. 6.
    Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H (2017) Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy. Eur Spine J 26(Suppl 1):236–242CrossRefGoogle Scholar
  7. 7.
    Elder BD, Sankey EW, Goodwin CR, Kosztowski TA, Lo SF, Bydon A, Wolinsky JP, Gokaslan ZL, Witham TF, Sciubba DM (2016) Surgical outcomes in patients with high spinal instability neoplasm score secondary to spinal giant cell tumors. Global Spine J 6(1):21–28CrossRefGoogle Scholar
  8. 8.
    Luksanapruksa P, Buchowski JM, Singhatanadgige W, Rose PC, Bumpass DB (2016) Management of spinal giant cell tumors. Spine J 16(2):259–269CrossRefGoogle Scholar
  9. 9.
    Charest-Morin R, Fisher CG, Varga PP, Gokaslan ZL, Rhines LD, Reynolds JJ, Dekutoski MB, Quraishi NA, Bilsky MH, Fehlings MG, Chou D, Germscheid NM, Luzzati A, Boriani S (2017) En bloc resection versus intralesional surgery in the treatment of giant cell tumor of the spine. Spine (Phila Pa 1976) 42(18):1383–1390CrossRefGoogle Scholar
  10. 10.
    Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res (153):106–120Google Scholar
  11. 11.
    Boriani S, Bandiera S, Casadei R, Boriani L, Donthineni R, Gasbarrini A, Pignotti E, Biagini R, Scwab JH (2012) Giant cell tumor of the mobile spine: a review of 49 cases. Spine (Phila Pa 1976) 37(1):E37–E45CrossRefGoogle Scholar
  12. 12.
    Goldschlager T, Dea N, Boyd M, Reynolds J, Patel S, Rhines LD, Mendel E, Pacheco M, Ramos E, Mattei TA, Fisher CG (2015) Giant cell tumors of the spine: has denosumab changed the treatment paradigm? J Neurosurg Spine 22(5):526–533CrossRefGoogle Scholar
  13. 13.
    Qi L, Li C, Wang N, Lian H, Lian M, He B, MD BG (2018) Efficacy of percutaneous vertebroplasty treatment of spinal tumors: a meta-analysis. Medicine (Baltimore) 97(3):e9575CrossRefGoogle Scholar
  14. 14.
    Martin C, McCarthy EF (2010) Giant cell tumor of the sacrum and spine: series of 23 cases and a review of the literature. Iowa Orthop J 30:69–75PubMedPubMedCentralGoogle Scholar
  15. 15.
    Alfawareh MD, Shah ID, Orief TI, Halawani MM, Attia WI, Almusrea KN (2015) Pediatric upper cervical spine giant cell tumor: case report. Global Spine J 5(4):e28–e33CrossRefGoogle Scholar
  16. 16.
    Kim SC, Cho W, Chang U, Youn SM (2015) Clinical outcome of treatment for patients with giant cell tumor in spine. J Korean Neurosurg Soc 58(3):248–253CrossRefGoogle Scholar
  17. 17.
    Ma Y, Li J, Pan J, Yan W, Huang Q, Liu T, Yang X, Yang C, Xu W, Wei H, Xiao J (2016) Treatment options and prognosis for repeatedly recurrent giant cell tumor of the spine. Eur Spine J 25(12):4033–4042CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of NeurosurgeryGaziantep Medical Park HospitalGaziantepTurkey
  2. 2.Department of RadiologyGaziantep Medical Park HospitalGaziantepTurkey
  3. 3.Department of NeurosurgeryLokman Hekim HospitalAnkaraTurkey
  4. 4.Department of NeurosurgeryBahcesehir University School of MedicineİstanbulTurkey

Personalised recommendations